* Mesa Laboratories Inc MLAB.OQ reported a quarterly
adjusted
loss of 10 cents per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 2 cents per share.
* Revenue rose 0.4% to $50.65 million from a year ago;
analysts
expected $51.85 million.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had fallen by 1.9% this
quarter and
lost 24.2% so far this year.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $152.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 3 at 01:34 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.02 -0.10 Missed
Mar. 31 2023 0.37 0.11 Missed
Dec. 31 2022 0.14 0.08 Missed
Sep. 30 2022 -0.31 0.24 Beat